Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract
Language English Country Slovakia Media print
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Antigens, Neoplasm metabolism MeSH
- Cell Membrane enzymology pathology MeSH
- Adult MeSH
- Enzyme-Linked Immunosorbent Assay MeSH
- Immunoenzyme Techniques MeSH
- Carbonic Anhydrase IX MeSH
- Carbonic Anhydrases metabolism MeSH
- Carcinoma, Transitional Cell blood enzymology urine MeSH
- Kidney Pelvis enzymology pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Urinary Bladder enzymology pathology MeSH
- Biomarkers, Tumor metabolism MeSH
- Pilot Projects MeSH
- Prognosis MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Neoplasm Staging MeSH
- Case-Control Studies MeSH
- Urologic Neoplasms blood enzymology urine MeSH
- Blotting, Western MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Names of Substances
- Antigens, Neoplasm MeSH
- CA9 protein, human MeSH Browser
- Carbonic Anhydrase IX MeSH
- Carbonic Anhydrases MeSH
- Biomarkers, Tumor MeSH
We investigated the expression of cell-associated CAIX protein in histological sections of the transitional cell carcinoma (TCC) of the urinary tract and of the soluble form of CAIX (s-CAIX) shed by the tumor into the serum and urine of TCC patients. A total of 23 patients with histologically confirmed TCC or squamous cell carcinoma (SCC) were enrolled in the pilot study. Sixteen healthy individuals served as controls. Membrane-bound CAIX was present in the tumor cells near the endoluminal surface. Necrosis was observed in only 4 samples. Using Western blots, s-CAIX concentrated from urine was visualized as a double band at 50 and 54 kDa. In most cases, the presence of s-CAIX in the urine correlated with CAIX expression in the tumor. On the other hand, s-CAIX did not exceed the normal level in the serum of TCC patients. Urine from patients with TCC of the urinary bladder and renal pelvis contained s-CAIX, allowing the detection of tumors in approximately 70% of the patients. Moreover, two additional patients with suspected, but unconfirmed bladder tumor, with s-CAIX detected in urine, developed tumors identified as TCC within six months. We suggest that after a simple, rapid and sensitive test, monitoring s-CAIX levels in urine will be developed, it may be useful for early detection of relapse in patients following transurethral tumor resection.
References provided by Crossref.org